In vivo studies have shown that CD40 is strongly expressed in podocytes of patients with both primary and post-transplant recurrent FSGS and the presence of circulating anti-CD40 antibodies are present in the serum of the same patients (78). Here, CD40 is linked to focal segmental glomerulosclerosis.